Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2033 of 6351
-
Group prenatal care may cut diabetes risk for obese moms-to-be
Prevention CompletedTo conduct a randomized trial to determine the effect of Targeted Lifestyle Change Group Prenatal Care (TLC) on maternal and neonatal outcomes in women at high risk for developing gestational diabetes mellitus (GDM).
Sponsor: University of North Carolina, Chapel Hill • Aim: Prevention
Last updated Jun 27, 2026 09:06 UTC
-
Whole-Body MRI could spot hidden breast cancer spread sooner
Diagnosis Recruiting nowThe aim of this study is to understand whether DWB-MRI (Diffusion Whole Body-Magnetic Resonance Imaging) is useful for early detection of locoregional or distant recurrence and whether early diagnosis influences the prognosis in high-risk populations thanks to the possibility of …
Sponsor: European Institute of Oncology • Aim: Diagnosis
Last updated Jun 27, 2026 08:08 UTC
-
New drug shows promise for Sjögren's syndrome in early trial
Disease control CompletedThe purpose of this study is to initially observe the safety and effectivity of RC18 in Participants with Primary Sjögren's Syndrome.
Phase 2 • Sponsor: RemeGen Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
When to add Weight-Loss pills? new study tests timing for teens
Disease control CompletedThis study will examine the timing and sequence of using adjunct obesity pharmacotherapy for adolescents with severe obesity who do not respond to lifestyle modification therapy alone.
Phase 2 • Sponsor: University of Minnesota • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Voice showdown: laser vs. radiation for early throat cancer
Disease control Recruiting nowLaser surgery and radiotherapy are well-established standards of care for unilateral stage 0 \& I carcinoma in situ (Cais) and squamous cell carcinoma of glottic larynx (SCCGL). Based on meta-analyses, functional and oncological outcome after both treatment modalities are compara…
Sponsor: Olgun Elicin • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Tablet VR game calms kids before surgery – no needles needed
Symptom relief CompletedPreoperative anxiety (PA) affects up to 5 million children in North America each year and is associated with adverse medical, psychological, and behavioral effects. Children who are highly anxious often require more medications during surgical procedures and take longer to recove…
Sponsor: McMaster University • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
Targeted pill shows promise for rare genetic tumor types
Disease control CompletedThe purpose of this study is to evaluate the efficacy of erdafitinib in terms of overall response rate (ORR) in adult and pediatric participants with advanced solid tumors with fibroblast growth factor receptor (FGFR) alterations (mutations or gene fusions). It will also evaluate…
Phase 2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New drug combo aims to shrink plasma cell tumors
Disease control OngoingThe purpose of this study is to investigate if the combination of CC-486 with lenalidomide and radiation therapy is a safe and effective treatment for plasmacytoma.
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Can a simple eyeglass test sharpen vision in keratoconus?
Knowledge-focused CompletedKeratoconus is a rare evolving corneal ectasia that alters visual acuity. To improve spectacle-corrected visual acuity, various subjective refraction techniques can be used. The subjective refraction techniques of keratoconus-carrying patients have never been studied. The main …
Sponsor: University Hospital, Clermont-Ferrand • Aim: Knowledge-focused
Last updated Aug 09, 2026 00:00 UTC
-
New pill for ALS passes safety check in 185-Patient trial
Disease control CompletedThe objective of this study is to evaluate the long-term safety and tolerability of oral edaravone in subjects with Amyotrophic Lateral Sclerosis (ALS) over 24 and 48 weeks.
Phase 3 • Sponsor: Shionogi • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Stroke recovery drug shows promise in major trial
Disease control CompletedThe main purpose of the clinical trial is to evaluate the efficacy and safety of Mexidol® in sequential treatment for patients in the acute and early recovery periods of ischemic stroke compared to placebo. The effect of adding Mexidol® to standard therapy on the degree of impair…
Phase 3 • Sponsor: Pharmasoft • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
40 VA hospitals test cheap drug to save kidneys in diabetes
Disease control OngoingPentoxifylline (PTX) is a medication that has been on the market since 1984 for use in disease in the blood vessels of the legs. There is some preliminary information that it may protect the kidneys from damage due to diabetes and other diseases. "Pentoxifylline in Diabetic Kidne…
Phase 4 • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
One-Shot radiation may ease cancer pain as well as multiple sessions
Symptom relief Recruiting nowThis phase II trial studies how well single-fraction stereotactic body radiation therapy (SBRT) works when compared to standard radiation therapy in treating patients with cancer that has spread to other places in the body (metastatic). Stereotactic body radiation therapy uses sp…
Phase 2 • Sponsor: Roswell Park Cancer Institute • Aim: Symptom relief
Last updated Jun 27, 2026 12:26 UTC
-
New pill shows promise against Hard-to-Treat blood cancers
Disease control OngoingThis is a Phase I/II, multicenter, open-label study to evaluate the safety, efficacy, tolerability, and pharmacokinetics of a novel BTK inhibitor, Orelabrutinib (ICP-022) in Patients with B-cell malignancies. The study contains two parts, Part 1 (dose escalation) and Part 2 (dose…
Phase 1/2 • Sponsor: Beijing InnoCare Pharma Tech Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Are former NFL players at higher risk for brain decline? new study aims to find out
Knowledge-focused Recruiting nowThis project will define the prevalence of brain health (i.e., normal cognitive, neuromotor, behavioral function) in living professional football retirees and group-matched controls through a comprehensive assessment of clinical, neuroimaging, and biomarker measures.
Sponsor: David Okonkwo, MD, PhD • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
Experimental drug combo targets tough leukemia
Disease control OngoingThe main purpose of this study is to learn about the safety and tolerability of an experimental drug, Venetoclax, when it is given along with Decitabine in subjects diagnosed with acute myeloid leukemia (AML).
Phase 1 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New online CBT program shows promise for teen emotional disorders
Symptom relief CompletedThis study represents the first research program to assess the efficacy of transdiagnostic cognitive behavior therapy (T-CBT) delivered via internet for anxiety and depression in adolescents. The primary aim of the study was to implement the program AMTE (Aprende a Manejar tus Em…
Sponsor: Universidad Nacional de Educación a Distancia • Aim: Symptom relief
Last updated Jun 27, 2026 12:33 UTC
-
New hope for rare blood disorder: drug targets overactive immune cells
Disease control OngoingThis phase II trial studies how well ruxolitinib works in treating patients with hypereosinophilic syndrome or primary eosinophilic disorders.
Phase 2 • Sponsor: Stanford University • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New pill shows promise for Hard-to-Treat breast cancer
Disease control OngoingThe purpose of this study is to test the safety and tolerability of PMD-026 in patients with metastatic breast cancer. PMD-026 is a targeted oral agent designed to kill tumor cells in metastatic breast cancer.
Phase 1/2 • Sponsor: Phoenix Molecular Designs • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
App and peer support aim to boost HIV prevention for people leaving jail
Prevention CompletedThis study will provide HIV prevention and related support services to men who have sex with men and transgender women who have substance use disorders and are either leaving jail or recently released from jail. The researchers will compare the utilization of HIV prevention and o…
Sponsor: University of California, Los Angeles • Aim: Prevention
Last updated Jun 27, 2026 12:35 UTC